Okla. Stat. tit. 56, § 56-4003

This is the official text of Okla. Stat. tit. 56, § 56-4003, part of Oklahoma’s Stat. tit. 56, — part of the compiled statutory law of Oklahoma, published by the state as "Stat. tit. 56,." Browse the sections below, each linked to its official government source.

Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.

Biomarker testing coverage

Official statutory text

A. As used in this section:

1. "Biomarker", "biomarker testing", "consensus statement", and

"nationally recognized clinical practice guidelines" shall have the

same meaning as provided by Section 1 of this act; and

2. "Contracted entity" shall have the same meaning as provided

by Section 4002.2 of Title 56 of the Oklahoma Statutes.

B. The state Medicaid program shall cover biomarker testing in

accordance with the requirements provided by this section.

C. Biomarker testing shall be covered for the purposes of

diagnosis, treatment, appropriate management, or ongoing monitoring

of a member’s disease or condition when the test is supported by

medical and scientific evidence, including, but not limited to:

Oklahoma Statutes - Title 56. Poor Persons Page 322

1. Labeled indications for a United States Food and Drug

Administration (FDA)-approved or -cleared test;

2. Indicated tests for an FDA-approved drug;

3. Warnings and precautions on FDA-approved drug labels;

4. Centers for Medicare and Medicaid Services (CMS) national

coverage determinations or Medicare Administrative Contractor (MAC)

local coverage determinations; or

5. Nationally recognized clinical practice guidelines and

consensus statements.

D. Contracted entities under the state Medicaid program shall

provide biomarker testing at the same scope, duration, and frequency

as the Medicaid program otherwise provides to members.

E. If prior authorization is required for biomarker testing,

the contracted entity shall approve or deny a prior authorization

request and notify the member, the member’s provider, and any entity

requesting authorization of the service within seventy-two (72)

hours for non-urgent requests or within twenty-four (24) hours for

urgent requests.

F. The member and the member’s provider shall have access to

clear, readily accessible, and convenient processes to request an

exception to a coverage policy for biomarker testing of the state

Medicaid program. The process shall be made readily accessible to

all participating providers and members online.

Status: in_force · Read it on the official government site

Need a lawyer in Oklahoma?

Find a Oklahoma lawyer
About this page: Statute text is reproduced from official government publishers via the Open US Law dataset (Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine (Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.